Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin vs Metformin + Exenatide in Overweight/Obese PCOS
NCT04029272Phase 4Unknown
- Sponsor
- Peking Union Medical College Hospital
- Start
- Jul 2019
- Primary completion
- Feb 2020
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 4 trial of exenatide in polycystic ovary syndrome (PCOS), obesity, sponsored by Peking Union Medical College Hospital. Status: unknown.
02
Drugs
exenatide
03
Conditions
polycystic ovary syndrome (PCOS)obesity
Beyond the preview
Go deeper on NCT04029272.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04029272.